Your browser doesn't support javascript.
loading
Identification of nanobodies against hepatocellular carcinoma marker glypican-3.
Wang, Wenyi; Xu, Chang; Wang, Huanan; Jiang, Changan.
Affiliation
  • Wang W; Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, Hubei, 430074, China; Precision Medicine R&D Center, Zhuhai Institute of Advanc
  • Xu C; Precision Medicine R&D Center, Zhuhai Institute of Advanced Technology, Chinese Academy of Sciences, Zhuhai, Guangdong, 519080, China.
  • Wang H; Department of Respiratory Medicine, The 990th Hospital of Joint Logistics Support Force, Xinyang, Henan, 464000, China.
  • Jiang C; Precision Medicine R&D Center, Zhuhai Institute of Advanced Technology, Chinese Academy of Sciences, Zhuhai, Guangdong, 519080, China; Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, China.
Mol Immunol ; 131: 13-22, 2021 03.
Article in En | MEDLINE | ID: mdl-33453658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Glypicans / Single-Domain Antibodies / Liver Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Mol Immunol Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Glypicans / Single-Domain Antibodies / Liver Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Mol Immunol Year: 2021 Document type: Article Country of publication: